Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Christopher Summa

Orthopaedic Surgery of the Spine Soquel, CA Medical Doctor

NPI 1669548640 CMS profile 165984

3035 N. Main Street, Soquel, CA 95073

Open in the dashboard

General payments

$809,584

750 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$29,099

6 holdings reported · through program year 2025

Research they led as principal investigator

$356,909 paid to institutions, not to them · program years 2023–2025

Through program year 2025, Christopher Summa of Soquel, CA is reported in the CMS Open Payments database as having received $809,584 across 750 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $356,909 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $29,099 across 6 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 93rd percentile of Orthopaedic Surgery of the Spine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

13 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $103,104 109
2024 General $103,896 49
2023 General $112,263 94
2022 General $97,040 113
2021 General $190,158 158
2020 General $90,666 84
2019 General $112,458 143
2025 Ownership $8,822 1
2024 Ownership $2,088 1
2023 Ownership $2,088 1
2022 Ownership $2,259 1
2021 Ownership $2,642 1
2020 Ownership $11,200 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Christopher Summa
  • Orthopaedic Surgery of the Spine median
  • Middle half of Orthopaedic Surgery of the Spine
  • National median

In program year 2025, general payments to Christopher Summa were reported at $103,104. Among 1,704 Orthopaedic Surgery of the Spine profiles paid that year, the median was $2,061 and the middle half received between $347 and $14,651.

Show as a table
Year Christopher Summa Orthopaedic Surgery of the Spine median Middle half National median
2019 $112,458 $2,106 $337–$18,608 $163
2020 $90,666 $1,213 $156–$15,082 $114
2021 $190,158 $1,834 $271–$15,617 $132
2022 $97,040 $2,015 $320–$17,036 $149
2023 $112,263 $1,925 $336–$14,599 $160
2024 $103,896 $2,110 $341–$12,483 $164
2025 $103,104 $2,061 $347–$14,651 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Centinel Spine, LLC $306,690 163 payments
  2. NuVasive, Inc. $223,112 353 payments
  3. Providence Medical Technology, Inc. $101,523 61 payments
  4. Globus Medical, Inc. $66,282 90 payments
  5. Kyocera Medical Technologies, Inc. $52,956 6 payments
  6. SI-BONE, Inc. $28,246 30 payments
  7. Renovis Surgical Technologies, Inc. $20,633 1 payment
  8. Nalu Medical, Inc. $3,667 1 payment
  9. San Francisco Surgical Services, LLC $3,112 1 payment
  10. Alphatec Spine, Inc $1,290 8 payments
  11. Other $2,072 36 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $575,425 149 payments
  2. Travel and Lodging $115,635 334 payments
  3. Royalty or License $93,590 9 payments
  4. Food and Beverage $14,905 253 payments
  5. Current or prospective ownership or investment interest $6,779 2 payments
  6. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $3,200 1 payment
  7. Entertainment $51 2 payments
Products named General payments · program years 2019–2025
  1. PRODISC L $208,078 94 payments
  2. PRODISC C $71,990 20 payments
  3. TLIF Spine/Spine Surgery $63,067 81 payments
  4. TLIF Spine/Spine Surgery $51,692 78 payments
  5. XLIF Spine/Spine Surgery $40,912 40 payments
  6. XLIF Spine/Spine Surgery $30,569 67 payments
  7. IFUSE IMPLANT $28,177 29 payments
  8. CAVUX Cervical Cage $26,290 17 payments
  9. DTRAX Spinal System $26,290 17 payments
  10. BIOLOGIX Allograft Bone $26,290 17 payments
  11. Other $108,892 238 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 2 drugs

Part D claims

37

Median for Neurosurgery: 83

Drug cost

$228

Median for Neurosurgery: $872

Branded share of claims

32.4%

Median for Neurosurgery: 16.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 25 $150
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 12 $78

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 69 billing codes

Paid by Medicare

$353,490

Medicare's payments for the services billed

Medicare patients

497

Average age 74

Services billed

1,237

270 women, 227 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Arthritis 75%
High blood pressure 69%
Osteoporosis 26%
Depression 25%
Diabetes 23%
Ischemic heart disease 23%
Atrial fibrillation 18%
Chronic kidney disease 17%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

750 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery of the Spine in California

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record